Sökresultat

Filtyp

Din sökning på "*" gav 535371 sökträffar

C-KIT Signaling Depends on Microphthalmia-Associated Transcription Factor for Effects on Cell Proliferation.

The development of melanocytes is regulated by the tyrosine kinase receptor c-KIT and the basic-helix-loop-helix-leucine zipper transcription factor Mitf. These essential melanocyte survival regulators are also well known oncogenic factors in malignant melanoma. Despite their importance, not much is known about the regulatory mechanisms and signaling pathways involved. In this study, we therefore

Influence of inhomogeneities in a stratified ground on the field of a circular loop antenna

This paper extends earlier works on three-dimensional scattering from a finite obstacle in a stratified halfspace, treated by means of the T-matrix method. In this paper we consider a general source configuration above the ground, that excites the subsurface medium and its inhomogeneity. Explicit expressions are given for the magnetic dipole, the circular, and rectangular antenna loops. Numerical

Determinants for malignancy in surgically treated adrenal lesions.

PURPOSE: It is difficult to definitively rule out or establish malignancy pre-operatively in patients with adrenal lesions referred for adrenal surgery. The aim of this study was to identify risk factors for a malignant diagnosis in patients treated with adrenalectomy. METHODS: Consecutive adrenalectomies at the Department of Surgery, Lund University Hospital between 2000 and 2009 were identified.

Developmental Aspects of Text Production in Writing and Speech

This thesis aims at describing the developmental patterns of text production in four text types: spoken and written narrative texts, and spoken and written expository texts (n=316), produced by four age groups: 10-year-olds, 13-year-olds, 17-year-olds and university students (n=79). It explores material from an experimental study with a cross-sectional design comprising spoken texts recorded on vi

Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study.

Men with germline breast cancer 1, early onset (BRCA1) or breast cancer 2, early onset (BRCA2) gene mutations have a higher risk of developing prostate cancer (PCa) than noncarriers. IMPACT (Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in BRCA1/2 mutation carriers and controls) is an international consortium of 62 centres in 20 countries evaluating the

Estimation of patient doses from X-ray examinations in the Bryansk region hospitals

During 2012 - 2013 a study to evaluate conventional X-ray procedures and patient doses in Klintzi and Novozibkov areas of Bryansk region, Russia, was conducted. X-ray operation parameters included quality assurance of equipment, collection of procedure parameters and clinical practice evaluation. Effective doses were calculated for each selected procedure and dose distributions were established. 7

Some Aspects of Mobile Map Services

The technology of today, with the use of computers and the Internet, has enabled new types of map usage. Screen maps provide possibilities that could never be offered by standard paper maps, and allow maps to be integrated into information services. Mobile map services are information services adapted to mobility; using small screen presentation devices and communication networks to access various

Patient-reported 28 swollen and tender joint counts accurately represent RA disease activity and can be used to assess therapy responses at the group level.

Objective. Formal joint assessments are critically important to improve rheumatological care of patients with RA. The aim of this study was to determine the usefulness of patient-recorded 28 tender joint counts (TJCs) and swollen joint counts (SJCs) using a tablet personal computer and to explore the possibility of using patient-recorded data to calculate 28-joint DAS (DAS-28) and EULAR response.

Molecular mechanisms of resistance to Rituximab and pharmacologic strategies for its circumvention.

The introduction of Rituximab has greatly improved therapeutic options for patients with B-cell non-Hodgkin lymphoma (B-NHL). However, a substantial fraction of patients with aggressive B-NHL fails first-line therapy, and most patients with relapsing indolent B-NHL eventually acquire Rituximab resistance. Molecular understanding of the underlying mechanisms facilitates the development of pharmacol